GlassScriptPhysician profile
Candice J Geist
NPI 1003175696
$1,025.59
in general payments reported to CMS, 2019-2025
13 companies · $68.44 in 2025
The $68.44 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.49 · 2020: $27.19 · 2021: $100 · 2022: $141 · 2023: $569 · 2024: $36.97 · 2025: $68.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $650 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $649.62 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $318.05 | 2021-2025 | Thinprep 2000 Processor, Aptima |
| Abbvie INC. | $218.35 | 2022-2023 | |
| Astellas Pharma US INC | $116.13 | 2023 | Veozah |
| Therapeuticsmd, INC. | $77.23 | 2019-2022 | |
| Organon LLC | $61.18 | 2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $42.13 | 2022-2023 | |
| Coopersurgical, INC. | $41.69 | 2023 | Summit Doppler, Paragard T 380a |
| Exeltis, USA INC. | $41.10 | 2019-2023 | Slynd |
| Pfizer INC. | $31.39 | 2023 | |
| Merck Sharp & Dohme LLC | $27.06 | 2019-2023 | Gardasil 9 |
| Daiichi Sankyo INC. | $20.53 | 2023 | Injectafer |
| Allergan, INC. | $16.09 | 2020 | |
| Gynesonics, INC. | $14.66 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candice Geist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.